Biblio
Next generation organoid engineering to replace animals in cancer drug testing. Biochem Pharmacol. 2023:115586.
. hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia. Cell Rep Med. 2022;3(8):100717.